Comparison of the Efficacy and Safety of PD‐1/PD‐L1 Inhibitors in the Treatment of Small Cell Lung Cancer

Comparison of the Efficacy and Safety of PD‐1/PD‐L1 Inhibitors in the Treatment of Small Cell Lung Cancer

ABSTRACT Objective This study aims to evaluate the efficacy and safety of PD‐1/PD‐L1 inhibitors in treating small‐cell lung cancer (SCLC) and determine the role of PD‐1 monoclonal antibodies in improving patient outcomes. Methods A retrospective analysis was performed on 37 SCLC patients who receive...

Full description

Saved in:
Bibliographic Details
Main Authors: Qichen Zhang, Xiaojuan Han, Jiayi Liu, Hui Qiao
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Cancer Reports
Subjects:
adverse reactions
efficacy evaluation
PD‐L1/PD‐1
small cell lung cancer (SCLC)
Online Access:https://doi.org/10.1002/cnr2.70081
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cnr2.70081

Similar Items